Novavax shots to join COVID vaccine rollout

The COVID vaccine rollout will soon include a third option, after the Food and Drug Administration on Tuesday authorized an updated Novavax shot for emergency use in individuals 12 years of age and older.

Why it matters: Novavax's product will be the only non-mRNA COVID-19 vaccine available in the U.S. and could potentially ease logistical issues that have disrupted the rollout amid a surge in new cases.

The FDA authorization was the last regulatory hurdle for Maryland-based Novavax. The updated vaccine is covered under recommendations the Centers for Disease Control...